Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Cardiovascular Drugs and Therapy|May 27, 2003
Cardiovascular therapy in patients with renal insufficiencyLuis M Ruilope, Julian SeguraIntegrated Blood Pressure Control|September 28, 2011
Clinical utility of fixed-combination telmisartan-amlodipine in the treatment of hypertensionJulian Segura, Luis M RuilopeHeart Failure Clinics|September 2, 2008
Hyperkalemia risk and treatment of heart failureJulian Segura, Luis M RuilopeClinical and Experimental Hypertension (New York, N.Y. : 1993)|July 18, 2008
The importance of integrated risk management when treating patients with hypertension: benefits of angiotensin II receptor antagonist therapyLuis M Ruilope, Julian SeguraEuropean Journal of Clinical Investigation|March 13, 2012
Are there new threshold and goals in the treatment of arterial hypertension?Julian Segura, Luis M RuilopeExpert Opinion on Pharmacotherapy|October 28, 2010
ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendationsLuis M Ruilope, Julian SeguraCurrent Hypertension Reports|November 4, 2010
Dual-acting angiotensin receptor-neprilysin inhibitionJulian Segura, Luis M RuilopeClinical Therapeutics|January 30, 2004
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidenceLuis M Ruilope, Julian SeguraJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 2, 2009
Kidney protection: a key target in the management of patients with diabetesLuis M Ruilope, Julian SeguraVascular Health and Risk Management|October 2, 2013
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazideJulian Segura, Luis Miguel RuilopePageof 7